Physician

Adam Spivack, M.D.

According to 2025 Medicare claims, Adam Spivack, M.D. (NPI: 1154585321) practices vascular surgery in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP (NPI: 1952333460; TIN: 951750445) and primary practice location at 92618-3734.

Spivack's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 14 traditional Medicare patients, billed 23 HCPCS/CPT codes, and received $3,321 in Medicare payments. Part D data shows 160 prescription claims across 71 beneficiaries totaling $7,201 in drug costs, led by Pentoxifylline (Pentoxifylline). Open Payments data shows 1 records totaling $24. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,936 and ending at $7,201. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7K$3.3K2018 Medicare payment: $1,135 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,291 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,321 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181225$1,135
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20232037$3,291
20241423$3,321

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.2K$12K2015 Drug cost: $3,936 (USD; Tot_Drug_Cst)2016 Drug cost: $2,302 (USD; Tot_Drug_Cst)2017 Drug cost: $3,856 (USD; Tot_Drug_Cst)2018 Drug cost: $1,502 (USD; Tot_Drug_Cst)2019 Drug cost: $5,161 (USD; Tot_Drug_Cst)2020 Drug cost: $12,477 (USD; Tot_Drug_Cst)2021 Drug cost: $10,346 (USD; Tot_Drug_Cst)2022 Drug cost: $7,836 (USD; Tot_Drug_Cst)2023 Drug cost: $6,082 (USD; Tot_Drug_Cst)2024 Drug cost: $7,201 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153977$3,936
20163377$2,302
20174783$3,856
20183565$1,502
20194792$5,161
202059173$12,477
202168164$10,346
202265192$7,836
202343151$6,082
202471160$7,201

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PentoxifyllinePentoxifylline12360$529
ClopidogrelClopidogrel Bisulfate302,470$508
CilostazolCilostazol12600$384
GabapentinGabapentin17929$306
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen3464$265

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$24Inari Medical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Spivack, M.D.?

Tedicare shows public-source Medicare data for Adam Spivack, M.D. (NPI 1154585321), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Spivack, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Spivack, M.D.?

Adam Spivack, M.D. is linked to SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP (billing NPI 1952333460) in the available physician profile data.

Does Adam Spivack, M.D. have Open Payments data?

Adam Spivack, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.